Letter to the Editor: Comment on Raad et al’s “Adalimumab for the Treatment of Non-Infectious Uveitis: A Real Life Experience”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Letter to the Editor: Comment on Raad et al’s “Adalimumab for the Treatment of Non-Infectious Uveitis: A Real Life Experience”

Published:2024-06-07 Issue: Volume: Page:1-1
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Samalia Priya¹²^ORCID,Niederer Rachael³⁴

Affiliation:

1. Department of Ophthalmology, Te Whatu Ora Southern/Health New Zealand Southern, Dunedin, New Zealand

2. Department of Medicine, University of Otago, Otago, New Zealand

3. Department of Ophthalmology, Te Whatu Ora Te Toka Tumai/Health New Zealand Auckland, Auckland, New Zealand

4. Department of Ophthalmology, University of Auckland, Auckland, New Zealand

Funder

no funding associated

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2024.2362879

Reference5 articles.

1. The Immunogenicity of Biologic Therapies

2. Antidrug Antibodies to Tumor Necrosis Factor α Inhibitors in Patients With Noninfectious Uveitis

3. Uveitis in the Aging Eye: Incidence, Patterns, and Differential Diagnosis

4. The spectrum of paediatric uveitis in New Zealand;Samalia PD;N Z Med J,2023

5. Review of de novo uveitis in older adults presenting to a large tertiary centre

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP